🇺🇸 FDA
Pipeline program

CT-P55, Cosentyx 150 mg solution for injection in pre-filled syringe

CT-P55 3.1

Phase 3 small_molecule active

Quick answer

CT-P55, Cosentyx 150 mg solution for injection in pre-filled syringe for Plaque psoriasis is a Phase 3 program (small_molecule) at Celltrion Healthcare Hungary Kft. with 1 ClinicalTrials.gov record(s).

Program details

Company
Celltrion Healthcare Hungary Kft.
Indication
Plaque psoriasis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials